Dara Biosciences, Inc. (DARA) Reports Q3 Loss of $0.16

Dara Biosciences, Inc. (NASDAQ: DARA) reported Q3 EPS of ($0.16), versus ($0.18) reported last year.

For earnings history and earnings-related data on Dara Biosciences, Inc. (DARA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Cytokinetics (CYTK) PT Raised to $110 at Barclays
• Citi raises Cooper Companies price target to $80, keeps Neutral